Novavax, Inc. (NVAX)
9.29
-0.07
(-0.75%)
USD |
NASDAQ |
May 07, 15:28
Novavax SG&A Expense (TTM) : 109.39M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.88B |
| Pfizer Inc. | 10.76B |
| Moderna, Inc. | 979.00M |
| Johnson & Johnson | 24.60B |
| Intellia Therapeutics, Inc. | 119.80M |